In a quiet hospital corridor, a family huddles together – not to discuss a diagnosis, but to decipher a multi-page bill filled with incomprehensible codes.
It’s a scene familiar to anyone who has navigated a health system on either side of the Atlantic, and it sits at the heart of a problem now drawing serious attention from London’s growing health-tech investment community: administrative waste estimated at a quarter of a trillion dollars annually across global healthcare systems.
For James Richman, the founder of healthcare revenue infrastructure firm OTLEN, the issue is not abstract. It’s personal.
A Personal Reckoning
Richman’s mission traces back to his father’s battle with cancer, during which he witnessed the system fight on two fronts – one against the disease, the other against a bureaucracy that delayed treatment authorisations and buried families in insurance paperwork. That experience was compounded by the loss of his daughter, which he attributes to data silos between specialists and breakdowns in communication during care handoffs.
“When you’re sitting in a hospital, you quickly realise the most advanced medical science in the world can be brought to its knees by a three-ring binder and a fax machine,” Richman says. “The system’s bureaucracy is its own chronic illness.”
It’s a diagnosis that will sound familiar to anyone following the debate around NHS digital transformation, where similar frustrations – fragmented IT systems, paper-based referrals, and disconnected specialist records – have been flagged repeatedly by both patients and clinicians in the UK.
An Investor’s Eye on a Systemic Problem
Before turning to healthcare, Richman built his career as an investor, developing a talent for spotting hidden patterns in financial systems. He applied the same forensic approach to what he saw in healthcare administration – treating the chaos not as a series of isolated cost centres, but as symptoms of a deeper operational disease.
“In finance, you follow the money,” Richman explains. “I learned that in healthcare, if you follow the money, you uncover the system’s deepest dysfunctions. Revenue leakage isn’t a financial problem – it’s a symptom of operational disease that ultimately impacts the patient.”
That framing has particular resonance for UK readers at a moment when NHS trusts and private healthcare providers alike are under pressure to do more with constrained budgets, and when revenue cycle inefficiencies – denied claims, billing errors, delayed reimbursements – are increasingly recognised as a drain on resources that could otherwise fund staffing or technology upgrades.
“Most people look at healthcare and see a clinical problem. I looked at it and saw a balance sheet bleeding out. The same patterns I used to find in undervalued markets… inefficiency hiding in plain sight, value trapped by outdated systems – were everywhere in hospital administration, only the stakes were measured in lives, not just returns.”
That investor’s instinct pointed him toward a healthcare economy riddled with structural waste: a US system where an estimated $265 billion is lost annually to billing inefficiencies, and a UK landscape where NHS administrative costs have drawn sustained scrutiny from bodies including the National Audit Office. For Richman, the core insight was that healthcare’s financial dysfunction and its clinical dysfunction were not separate problems – they were the same problem, viewed from different angles.
The Solution: A “Digital Tourniquet” for Healthcare’s Leaks
OTLEN’s answer is technology that identifies and stops revenue leakage in real time – what Richman calls a “digital tourniquet.” For a hospital network, he says, a flawed revenue cycle is like running a marathon with a slow internal bleed: every denied claim and billing error represents money that should have gone toward better care.
That same forensic approach extends across the wider healthcare ecosystem. For health systems and provider networks operating on thin margins, Richman notes, financial strain is often the hidden threat behind operational setbacks – administrative inefficiency quietly draining resources that should go toward patient care. By automating revenue operations end-to-end, organisations can build a more resilient financial foundation that lets clinical teams focus on care delivery rather than paperwork – a point with clear relevance for London’s expanding health-tech and digital health sector.
Measuring Success Differently
For Richman, the ultimate measure of success isn’t the balance sheet – it’s the reduction of administrative burden on clinicians, a major driver of physician burnout that affects close to half of all doctors in the US, and one increasingly cited in UK workforce reports as well.
“We don’t build technology for the sake of technology,” he says. “We build it to eliminate the friction that distracts from the mission. Every minute a doctor spends fighting a claim denial is a minute they are not with a patient. That is the ROI we are focused on.”
The Bigger Picture
Richman’s story – personal loss, sharpened by an investor’s analytical instincts, executed through purpose-built technology – is increasingly part of a wider conversation among UK health-tech founders and investors about where genuine impact lies: not necessarily in flashy clinical AI, but in the unglamorous plumbing of healthcare finance and operations.
The tools to build a more efficient, more humane healthcare system exist. The question, as Richman puts it, is whether the industry has the collective will to use them.
